Enanta Pharmaceuticals
ENTA
#7625
Rank
NZ$0.65 B
Marketcap
NZ$22.69
Share price
2.69%
Change (1 day)
144.34%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -NZ$0.14 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are NZ$65.32 Million. In 2024 the company made an earning of -NZ$0.17 Billion, an increase over its 2023 earnings that were of -NZ$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.14 Billion-22.62%
2024 -NZ$0.17 Billion-23.87%
2023 -NZ$0.23 Billion4.39%
2022 -NZ$0.22 Billion-4.4%
2021 -NZ$0.23 Billion91.12%
2020 -NZ$0.12 Billion-407.13%
2019 NZ$38.06 M-78.63%
2018 NZ$0.17 B117.97%
2017 NZ$81.72 M-574.65%
2016 -NZ$17.22 Million-110.83%
2015 NZ$0.15 B-4.5%
2014 NZ$0.16 B-638.53%
2013 -NZ$30.93 Million-137.98%
2012 NZ$81.4 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$58.70 B-44,324.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$28.61 B-21,653.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
NZ$11.54 B-8,795.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$8.14 B-6,237.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.23 B-29,655.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.32 B-12,395.04%๐Ÿ‡บ๐Ÿ‡ธ USA